USRE33565E - Prevention and treatment of rheumatioid arthritis - Google Patents
Prevention and treatment of rheumatioid arthritis Download PDFInfo
- Publication number
- USRE33565E USRE33565E US07/231,219 US23121988A USRE33565E US RE33565 E USRE33565 E US RE33565E US 23121988 A US23121988 A US 23121988A US RE33565 E USRE33565 E US RE33565E
- Authority
- US
- United States
- Prior art keywords
- type
- streptococcus pyogenes
- streptococcus
- milk
- pyogenes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
TABLE 1 ______________________________________ Bacterial Antigens ORGANISM *ATCC NO. ______________________________________ Staphylococcus aureus 11631 Staphylococcus epidermidis 155 Streptococcus pyogenes,A. Type 1 8671 Streptococcus pyogenes,A. Type 3 10389 Streptococcus pyogenes,A. Type 5 12347 Streptococcus pyogenes,A. Type 8 12349 Streptococcus pyogenes,A. Type 12 11434 Streptococcus pyogenes, A. Type 14 12972 Streptococcus pyogenes, A. Type 18 12357 Streptococcus pyogenes, A. Type 22 10403 Aerobacter aerogenes 884 Escherichia coli 26 Salmonella enteritidis 13076 Pseudomonas aeruginosa 7700 Klebsiella pneumoniae 9590 Salmonella typhimurium 13311 Haemophilus influenzae 9333 Streptococcus viridans 6249 Proteus vulgaris 13315 Shigella dysenteriae 11835 Streptococcus, Group B Diplococcus pneumoniae Streptococcus mutans Corynebacterium, Acne, Types 1 & 2 ______________________________________ *American Type Culture Collection, 12301 Parklawn Dr., Rockville, Md. 20852
TABLE 2 ______________________________________ Quantitative and Qualitative Analysis of Antibacterial Milk Proteins 35.6% Fat 1.0% Carbohydrates 52% Minerals 7.8% Moisture 3.5% Each reliquified quart of 3-4 ounces of non-fat dry milk contains approximately: 1200 mg calcium 157% 935 mg phosphorous 125% 0.3 mg thiamine 32% 1.78 mg riboflavin 140% 1.04mg niacin 10% 324 Calories ______________________________________
TABLE 3 __________________________________________________________________________ Periods of Treatment Regimen Observation Placebo Immune Mean Control Immune Mean C.V.* Mean C.V.* Difference P __________________________________________________________________________ A.M. Stiffness 27 24 0.322 95.7 0.679 35.6 -0.347 0.0001 Joint Pain a. Shoulder 27 24 0.954 67.1 0.716 60.2 +0.238 0.0420 b. Elbow 27 24 0.752 83.7 0.613 65.9 +0.139 0.0511 c. Wrist 27 24 0.824 73.6 0.539 74.8 +0.285 0.0010 d. Hand 27 24 1.073 54.7 0.828 56.5 +0.245 0.0011 e. Hip 27 24 0.533 90.3 0.227 135.0 +0.306 0.0005 f. Knee 27 24 0.904 74.1 0.683 59.0 +0.221 0.0015 g. Ankle 26 22 0.7811 66.9 0.659 65.7 +0.1221 0.0127 h. Feet 26 22 0.948 63.7 0.729 50.9 +0.219 0.0010 Pills 27 24 20.663 104.1 16.515 101.3 +4.148 0.0405 Other 27 24 0.325 140.7 0.244 175.6 +0.081 0.0276 Medication ADL 27 24 2.224 36.1 1.874 29.1 +0.350 0.0023 Monthly change a. Pain 27 24 1.903 21.8 2.247 14.1 -0.344 0.0042 b. Stiffness 27 24 1.985 18.8 2.254 12.4 -0.269 0.0024 c. Swelling 27 24 1.924 17.9 2.117 13.3 -0.193 0.00153 ESR 25 23 36.293 29.7 35.922 38.2 +0.371 0.7376 RF 27 24 6.698 45.5 6.834 41.7 -0.136 0.9635 __________________________________________________________________________ *Coefficient of variation.
Claims (4)
______________________________________ ORGANISMS ______________________________________ Staphylococcus aureus Staphylococcus epidermidis Streptococcus pyogenes, A. Type 1 Streptococcus pyogenes, A. Type 3 Streptococcus pyogenes, A. Type 5 Streptococcus pyogenes, A. Type 8 Streptococcus pyogenes, A. Type 12 Streptococcus pyogenes, A. Type 14 Streptococcus pyogenes, A. Type 18 Streptococcus pyogenes, A. Type 22 Aerobacter aerogenes Escherichia coli Salmonella enteritidis Pseudomonas aeruginosa Klebsiella pneumoniae Salmonella typhimurium Haemophilus influenzae Streptococcus viridans Proteus vulgaris Shigella dysenteriae Streptococcus, Group B Diplococcus pneumoniae Streptococcus mutans Corynebacterium, Acne, Types 1 & 2 ______________________________________
______________________________________ ORGANISM *ATCC NO. ______________________________________ Staphylococcus aureus 11631 Staphylococcus epidermidis 155 Streptococcus pyogenes, A. Type 1 8671 Streptococcus pyogenes, A. Type 3 10389 Streptococcus pyogenes, A. Type 5 12347 Streptococcus pyogenes, A. Type 8 12349 Streptococcus pyogenes, A. Type 12 11434 Streptococcus pyogenes, A. Type 14 12972 Streptococcus pyogenes, A. Type 18 12357 Streptococcus pyogenes, A. Type 22 10403 Aerobacter aerogenes 884 Escherichia coli 26 Salmonella enteritidis 13076 Pseudomonas aeruginosa 7700 Klebsiella pneumoniae 9590 Salmonella typhimurium 13311 Haemophilus influenzae 9333 Streptococcus viridans 6249 Proteus vulgaris 13315 Shigella dysenteriae 11835 Streptococcus, Group B Diplococcus pneumoniae Streptococcus mutans Corynebacterium, Acne, Types 1 & 2 ______________________________________
______________________________________ ORGANISMS ______________________________________ Staphylococcus aureus Staphylococcus epidermidis Streptococcus pyogenes, A. Type 1 Streptococcus pyogenes, A. Type 3 Streptococcus pyogenes, A. Type 5 Streptococcus pyogenes, A. Type 8 Streptococcus pyogenes, A. Type 12 Streptococcus pyogenes, A. Type 14 Streptococcus pyogenes, A. Type 18 Streptococcus pyogenes, A. Type 22 Aerobacter aerogenes Escherichia coli Salmonella enteritidis Pseudomonas aeruginosa Klebsiella pneumoniae Salmonella typhimurium Haemophilus influenzae Streptococcus viridans Proteus vulgaris Shigella dysenteriae Streptococcus, Group B Diplococcus pneumoniae Streptococcus mutans Corynebacterium, Acne, Types 1 & 2 ______________________________________
______________________________________ Staphylococcus aureus 11631 Staphylococcus epidermidis 155 Streptococcus pyogenes, A. Type 1 8671 Streptococcus pyogenes, A. Type 3 10389 Streptococcus pyogenes, A. Type 5 12347 Streptococcus pyogenes, A. Type 8 12349 Streptococcus pyogenes, A. Type 12 11434 Streptococcus pyogenes, A. Type 14 12972 Streptococcus pyogenes, A. Type 18 12357 Streptococcus pyogenes, A. Type 22 10403 Aerobacter aerogenes 884 Escherichia coli 26 Salmonella enteritidis 13076 Pseudomonas aeruginosa 7700 Klebsiella pneumoniae 9590 Salmonella typhimurium 13311 Haemophilus influenzae 9333 Streptococcus viridans 6249 Proteus vulgaris 13315 Shigella dysenteriae 11835 Streptococcus, Group B Diplococcus pneumoniae Streptococcus mutans Corynebacterium, Acne, Types 1 & 2 ______________________________________
______________________________________ Staphylococcus aureus 11631 Staphylococcus epidermidis 155 Streptococcus pyogenes, A. Type 1 8671 Streptococcus pyogenes, A. Type 3 10389 Streptococcus pyogenes, A. Type 5 12347 Streptococcus pyogenes, A. Type 8 12349 Streptococcus pyogenes, A. Type 12 11434 Streptococcus pyogenes, A. Type 14 12972 Streptococcus pyogenes, A. Type 18 12357 Streptococcus pyogenes, A. Type 22 10403 Aerobacter aerogenes 884 Escherichia coli 26 Salmonella enteritidis 13076 Pseudomonas aeruginosa 7700 Klebsiella pneumoniae 9590 Salmonella typhimurium 13311 Haemophilus influenzae 9333 Streptococcus viridans 6249 Proteus vulgaris 13315 Shigella dysenteriae 11835 Streptococcus, Group B Diplococcus pneumoniae Streptococcus mutans Corynebacterium, Acne, Types 1 & 2 ______________________________________
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/231,219 USRE33565E (en) | 1978-02-06 | 1988-08-11 | Prevention and treatment of rheumatioid arthritis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87514078A | 1978-02-06 | 1978-02-06 | |
US07/231,219 USRE33565E (en) | 1978-02-06 | 1988-08-11 | Prevention and treatment of rheumatioid arthritis |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US87514078A Continuation | 1978-02-06 | 1978-02-06 | |
US06/558,909 Reissue US4732757A (en) | 1978-02-06 | 1983-12-09 | Prevention and treatment of rheumatoid arthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
USRE33565E true USRE33565E (en) | 1991-04-02 |
Family
ID=26924917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/231,219 Expired - Lifetime USRE33565E (en) | 1978-02-06 | 1988-08-11 | Prevention and treatment of rheumatioid arthritis |
Country Status (1)
Country | Link |
---|---|
US (1) | USRE33565E (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5871731A (en) * | 1995-12-22 | 1999-02-16 | Sprotte; Guenter | Oral administration of immunoglobulin preparations for treatment of chronic pain syndrome |
US20030099635A1 (en) * | 2001-10-04 | 2003-05-29 | Protein Therapeutics, Inc. | Use of oral gammaglobulin for the treatment of immune-mediated diseases |
US20030190314A1 (en) * | 2001-01-30 | 2003-10-09 | The Lauridsen Group | Methods and compositions of treatment for modulating the immune system of animals |
US6770280B1 (en) | 2001-11-15 | 2004-08-03 | Humanetics Corporation | Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product |
US6939543B2 (en) * | 1997-06-16 | 2005-09-06 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US20050271674A1 (en) * | 2001-01-30 | 2005-12-08 | Campbell Joy M | Methods and compositions for modulating the immune system of animals |
US20080139789A1 (en) * | 1990-10-22 | 2008-06-12 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection |
Citations (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE307975C (en) * | ||||
US1636445A (en) * | 1927-01-12 | 1927-07-19 | Small James Craig | Bacterium specific for rheumatic fever and method of utilizing the same in the prevention and treatment of rheumatic fever |
DE516403C (en) * | 1926-12-07 | 1931-01-22 | Carl Otto | Process for the manufacture of a vaccine against tuberculosis |
US2011225A (en) * | 1933-03-16 | 1935-08-13 | Krueger Albert Paul | Antigen and process of producing it |
US2166963A (en) * | 1936-11-19 | 1939-07-25 | Sharp & Dohme Inc | Antigenic polysaccharide complex |
US2385443A (en) * | 1942-01-31 | 1945-09-25 | Hoffmann Josef | Process of preparing concentrated toxoids and product produced thereby |
GB608596A (en) * | 1944-11-01 | 1948-09-17 | Willem Jacob Elias Mijnssen | Improvements relating to homeopathic preparations |
CA587849A (en) * | 1959-12-01 | E. Petersen William | Production of protective principle | |
GB837695A (en) * | 1955-04-07 | 1960-06-15 | William E Petersen | Method of producing products containing antibodies |
FI32472A (en) * | 1956-04-07 | 1962-05-10 | It is necessary to specify that the antigen is specific | |
DE1161659B (en) * | 1962-08-14 | 1964-01-23 | Mack Chem Pharm | Method for obtaining the polyarthritis antigen |
US3127318A (en) * | 1964-03-31 | Swine treatment | ||
US3128230A (en) * | 1961-04-04 | 1964-04-07 | Sunbury Milk Products Co | Milk having antibodies therein and process for producing same |
US3139382A (en) * | 1961-10-31 | 1964-06-30 | American Home Prod | Bacterins and process of producing the same |
GB988135A (en) * | 1963-01-14 | 1965-04-07 | Aquitaine Petrole | Preparation of hydroxythiols |
US3376198A (en) * | 1965-07-21 | 1968-04-02 | Collins Products Inc | Method of producing antibodies in milk |
US3480610A (en) * | 1967-03-20 | 1969-11-25 | Us Health Education & Welfare | Alkaline extraction of m protein from group a hemolytic streptococci and products thereof |
US3487148A (en) * | 1967-04-18 | 1969-12-30 | Us Health Education & Welfare | Partially digested m protein vaccine and method of making same |
US3532790A (en) * | 1968-02-23 | 1970-10-06 | Canadian Patents Dev | Somatic antigen vaccines from lysed inactivated bacteria and process for producing them |
GB1211876A (en) * | 1967-11-23 | 1970-11-11 | Twyford Lab Ltd | Improvements in and relating to prophylactic and therapeutic preparations |
US3553317A (en) * | 1969-06-02 | 1971-01-05 | Joseph B Michaelson | Ig-a antibody from lacteal fluids |
US3626057A (en) * | 1969-09-24 | 1971-12-07 | Immune Milk Co Of America Inc | Method of producing tetanus antitoxin |
US3646193A (en) * | 1969-07-25 | 1972-02-29 | Joseph B Michaelson | Iga antibody from lacteal fluids |
US3911108A (en) * | 1973-02-14 | 1975-10-07 | Diamond Shamrock Corp | Process of producing bovine milk products containing specific antibodies |
US3917818A (en) * | 1970-01-14 | 1975-11-04 | Agricura Labor Ltd | Treatment of mastitis in cows, the product for this treatment and to the production of said product |
US3962422A (en) * | 1975-02-18 | 1976-06-08 | Syntex (U.S.A.) Inc. | Method for immunizing nursing piglets against transmissible gastroenteritis(TGE) virus |
US3975517A (en) * | 1972-05-25 | 1976-08-17 | Canadian Patents And Development Limited | Enteric disease vaccine |
US4051235A (en) * | 1976-04-22 | 1977-09-27 | Plymate Robert R | Method of preparing bovine colostrum for use in treating livestock |
GB1505523A (en) * | 1974-08-22 | 1978-03-30 | Thomas & Betts Corp | Electrical contact |
US4141970A (en) * | 1975-05-07 | 1979-02-27 | Internationale Octrooimaatschappij "Octropa" B.V. | Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections |
US4160825A (en) * | 1975-08-29 | 1979-07-10 | Dennis Sikes | Antibody-active protein composition |
GB2013691A (en) * | 1978-02-06 | 1979-08-15 | Stolle Res & Dev | IgG Preparations |
US4284623A (en) * | 1979-11-09 | 1981-08-18 | Beck Lee R | Method of treating inflammation using bovine milk |
US4324782A (en) * | 1974-01-28 | 1982-04-13 | Beck Lee R | Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells |
EP0064103A1 (en) * | 1981-04-28 | 1982-11-10 | The Stolle Research And Development Corporation | Method of obtaining an anti-inflammatory bovine milk |
US4377569A (en) * | 1980-01-21 | 1983-03-22 | Plymate Robert R | Method of treating animals to resist infectious diseases |
US4402938A (en) * | 1980-05-29 | 1983-09-06 | Impro Products, Inc. | Food and the method of extracting the same from colostrum and milk |
-
1988
- 1988-08-11 US US07/231,219 patent/USRE33565E/en not_active Expired - Lifetime
Patent Citations (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3127318A (en) * | 1964-03-31 | Swine treatment | ||
CA587849A (en) * | 1959-12-01 | E. Petersen William | Production of protective principle | |
DE307975C (en) * | ||||
DE516403C (en) * | 1926-12-07 | 1931-01-22 | Carl Otto | Process for the manufacture of a vaccine against tuberculosis |
US1636445A (en) * | 1927-01-12 | 1927-07-19 | Small James Craig | Bacterium specific for rheumatic fever and method of utilizing the same in the prevention and treatment of rheumatic fever |
US2011225A (en) * | 1933-03-16 | 1935-08-13 | Krueger Albert Paul | Antigen and process of producing it |
US2166963A (en) * | 1936-11-19 | 1939-07-25 | Sharp & Dohme Inc | Antigenic polysaccharide complex |
US2385443A (en) * | 1942-01-31 | 1945-09-25 | Hoffmann Josef | Process of preparing concentrated toxoids and product produced thereby |
GB608596A (en) * | 1944-11-01 | 1948-09-17 | Willem Jacob Elias Mijnssen | Improvements relating to homeopathic preparations |
GB837695A (en) * | 1955-04-07 | 1960-06-15 | William E Petersen | Method of producing products containing antibodies |
FI32472A (en) * | 1956-04-07 | 1962-05-10 | It is necessary to specify that the antigen is specific | |
US3128230A (en) * | 1961-04-04 | 1964-04-07 | Sunbury Milk Products Co | Milk having antibodies therein and process for producing same |
US3139382A (en) * | 1961-10-31 | 1964-06-30 | American Home Prod | Bacterins and process of producing the same |
DE1161659B (en) * | 1962-08-14 | 1964-01-23 | Mack Chem Pharm | Method for obtaining the polyarthritis antigen |
US3461200A (en) * | 1962-08-14 | 1969-08-12 | Hartwig Mathies | Process for the recovery of polyarthritis antigen |
GB988135A (en) * | 1963-01-14 | 1965-04-07 | Aquitaine Petrole | Preparation of hydroxythiols |
US3376198A (en) * | 1965-07-21 | 1968-04-02 | Collins Products Inc | Method of producing antibodies in milk |
US3480610A (en) * | 1967-03-20 | 1969-11-25 | Us Health Education & Welfare | Alkaline extraction of m protein from group a hemolytic streptococci and products thereof |
US3487148A (en) * | 1967-04-18 | 1969-12-30 | Us Health Education & Welfare | Partially digested m protein vaccine and method of making same |
GB1211876A (en) * | 1967-11-23 | 1970-11-11 | Twyford Lab Ltd | Improvements in and relating to prophylactic and therapeutic preparations |
US3532790A (en) * | 1968-02-23 | 1970-10-06 | Canadian Patents Dev | Somatic antigen vaccines from lysed inactivated bacteria and process for producing them |
US3553317A (en) * | 1969-06-02 | 1971-01-05 | Joseph B Michaelson | Ig-a antibody from lacteal fluids |
US3646193A (en) * | 1969-07-25 | 1972-02-29 | Joseph B Michaelson | Iga antibody from lacteal fluids |
US3626057A (en) * | 1969-09-24 | 1971-12-07 | Immune Milk Co Of America Inc | Method of producing tetanus antitoxin |
US3917818A (en) * | 1970-01-14 | 1975-11-04 | Agricura Labor Ltd | Treatment of mastitis in cows, the product for this treatment and to the production of said product |
US3975517A (en) * | 1972-05-25 | 1976-08-17 | Canadian Patents And Development Limited | Enteric disease vaccine |
US3911108A (en) * | 1973-02-14 | 1975-10-07 | Diamond Shamrock Corp | Process of producing bovine milk products containing specific antibodies |
US4324782A (en) * | 1974-01-28 | 1982-04-13 | Beck Lee R | Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells |
GB1505523A (en) * | 1974-08-22 | 1978-03-30 | Thomas & Betts Corp | Electrical contact |
US3962422A (en) * | 1975-02-18 | 1976-06-08 | Syntex (U.S.A.) Inc. | Method for immunizing nursing piglets against transmissible gastroenteritis(TGE) virus |
US4141970A (en) * | 1975-05-07 | 1979-02-27 | Internationale Octrooimaatschappij "Octropa" B.V. | Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections |
US4160825A (en) * | 1975-08-29 | 1979-07-10 | Dennis Sikes | Antibody-active protein composition |
US4051235A (en) * | 1976-04-22 | 1977-09-27 | Plymate Robert R | Method of preparing bovine colostrum for use in treating livestock |
GB2013691A (en) * | 1978-02-06 | 1979-08-15 | Stolle Res & Dev | IgG Preparations |
US4284623A (en) * | 1979-11-09 | 1981-08-18 | Beck Lee R | Method of treating inflammation using bovine milk |
US4377569A (en) * | 1980-01-21 | 1983-03-22 | Plymate Robert R | Method of treating animals to resist infectious diseases |
US4402938A (en) * | 1980-05-29 | 1983-09-06 | Impro Products, Inc. | Food and the method of extracting the same from colostrum and milk |
EP0064103A1 (en) * | 1981-04-28 | 1982-11-10 | The Stolle Research And Development Corporation | Method of obtaining an anti-inflammatory bovine milk |
Non-Patent Citations (13)
Title |
---|
Bauer, W., Clark, W. S. and Dienes, L. (1961), The Practitioner 166:5. * |
Holm, U.S. patent application Ser. No. 628,987, of Nov. 15, 1945, Abstract Published O.G., Dec. 5, 1950, 1 page, Spec. pp. 1, 3, 4, 5 and 7. * |
Karel, A Dictionary of Antibiosis, Columbia U. Press, N.Y. (1951), pp. 203 208. * |
Karel, A Dictionary of Antibiosis, Columbia U. Press, N.Y. (1951), pp. 203-208. |
Lascelles Dairy Science Abstracts, vol. 25, No. 9 (1963), A Review of the Literature on Some Aspects of Immune Milk, pp. 359 364. * |
Lascelles Dairy Science Abstracts, vol. 25, No. 9 (1963), A Review of the Literature on Some Aspects of Immune Milk, pp. 359-364. |
Lewis Fanning, E. (1950), Ann. Rheum. Dis., Suppl. 9, Sabin, A. B. (1939), Science 89:228. * |
Lewis-Fanning, E. (1950), Ann. Rheum. Dis., Suppl. 9, Sabin, A. B. (1939), Science 89:228. |
McGhee et al., J. Dent. Res., Special Issue C, vol. 55 (1976), 206 214, Effective Immunity to Dental Caries: Studies of Active and Passive Immunity to Streptococus Mutans in Malnourished Rats. * |
McGhee et al., J. Dent. Res., Special Issue C, vol. 55 (1976), 206-214, Effective Immunity to Dental Caries: Studies of Active and Passive Immunity to Streptococus Mutans in Malnourished Rats. |
Sikes, D., Neher, G. M. and Doyle L. P. (1955), Am. J. Vet. Res. 16. * |
Vaughan (Hollander, Ed.), Arthritis and Allied Conditions, Lea and Febiger, Pa., 7th Ed. (1966), pp. 574 586. * |
Vaughan (Hollander, Ed.), Arthritis and Allied Conditions, Lea and Febiger, Pa., 7th Ed. (1966), pp. 574-586. |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080139789A1 (en) * | 1990-10-22 | 2008-06-12 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection |
US5871731A (en) * | 1995-12-22 | 1999-02-16 | Sprotte; Guenter | Oral administration of immunoglobulin preparations for treatment of chronic pain syndrome |
US6939543B2 (en) * | 1997-06-16 | 2005-09-06 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US20100221822A1 (en) * | 1997-06-16 | 2010-09-02 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US7884198B2 (en) | 1997-06-16 | 2011-02-08 | The Henry M. Jackon Foundation for the Advancement of Military Medicine | Polynucleotides encoding humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US20030190314A1 (en) * | 2001-01-30 | 2003-10-09 | The Lauridsen Group | Methods and compositions of treatment for modulating the immune system of animals |
US20050271674A1 (en) * | 2001-01-30 | 2005-12-08 | Campbell Joy M | Methods and compositions for modulating the immune system of animals |
US20080213263A1 (en) * | 2001-01-30 | 2008-09-04 | Apc, Inc. | Methods and compositions for treatment of immune dysfunction disorders |
US20030099635A1 (en) * | 2001-10-04 | 2003-05-29 | Protein Therapeutics, Inc. | Use of oral gammaglobulin for the treatment of immune-mediated diseases |
US6770280B1 (en) | 2001-11-15 | 2004-08-03 | Humanetics Corporation | Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4732757A (en) | Prevention and treatment of rheumatoid arthritis | |
US5772999A (en) | Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals | |
US5585098A (en) | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants | |
JPH0160455B2 (en) | ||
US20090258121A1 (en) | Method of producing nutritional products from human milk tissue and compositions thereof | |
Porter et al. | Intestinal antibody secretion in the young pig in response to oral immunization with Escherichia coli | |
NZ211030A (en) | Passive heterologous immunisation compositions based on antibodies from pre-immunised fowls and/or bovids | |
KR20000048855A (en) | Oral administration of chicken yolk antibodies to treat disease | |
JP2002501526A (en) | Method for producing immunoglobulin A in milk | |
USRE33565E (en) | Prevention and treatment of rheumatioid arthritis | |
Leskowitz | Tolerance | |
Tawfeek et al. | Efficacy of an infant formula containing anti-Escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: a field trial | |
Campbell et al. | Immune milk-a historical survey. | |
Keusch | Nutritional effects on response of children in developing countries to respiratory tract pathogens: implications for vaccine development | |
Bullen | Iron‐binding proteins and other factors in milk responsible for resistance to Escherichia coli | |
WO1999002188A1 (en) | Hen egg yolk antibodies to clostridium difficile antigens and use in therapy for pseudomembranous colitis | |
Bazin | The secretory antibody system | |
Glantz | Bacteriological and serological studies of Escherichia coli serotypes associated with calf scours | |
WO2016114677A1 (en) | Manufacture and use of hyperimmune egg pc2 | |
Nickerson et al. | Studies of immune and normal opsonins during experimental staphylococcal infection in rabbits | |
Brown | The treatment of urticaria and angioneurotic edema | |
US6770280B1 (en) | Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product | |
Winholt | Complement-Fixation in Whooping Cough | |
EP0255755A2 (en) | Vaccine preparation | |
GREENBLATT et al. | Administration to arthritis patients of a dietary supplement containing immune egg: an open-label pilot study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS - SMALL BUSINESS (ORIGINAL EVENT CODE: SM02); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
AS | Assignment |
Owner name: STOLLE MILK BIOLOGICS, INC., OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:STOLLE RESEARCH AND DEVELOPMENT CORPORATION;REEL/FRAME:010197/0973 Effective date: 19980616 |
|
AS | Assignment |
Owner name: STOLLE MILK BIOLOGICS, INC., OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:STOLLE RESEARCH AND DEVELOPMENT CORPORATION;REEL/FRAME:010197/0683 Effective date: 19980616 |
|
FPAY | Fee payment |
Year of fee payment: 12 |